Candida biofilms: antifungal resistance and emerging therapeutic options.
about
Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn's DiseaseCoriandrum sativum L. (Coriander) essential oil: antifungal activity and mode of action on Candida spp., and molecular targets affected in human whole-genome expressionCandida biofilms: an update.Real-time microscopic observation of Candida biofilm development and effects due to micafungin and fluconazole.Successful treatment of Candida parapsilosis mural endocarditis with combined caspofungin and voriconazoleAlcohol dehydrogenase restricts the ability of the pathogen Candida albicans to form a biofilm on catheter surfaces through an ethanol-based mechanismAspergillus fumigatus forms biofilms with reduced antifungal drug susceptibility on bronchial epithelial cells.Novel high-throughput screen against Candida albicans identifies antifungal potentiators and agents effective against biofilms.Alternative mating type configurations (a/α versus a/a or α/α) of Candida albicans result in alternative biofilms regulated by different pathways.Role of Fks1p and matrix glucan in Candida albicans biofilm resistance to an echinocandin, pyrimidine, and polyeneGold nanoparticles enhance methylene blue-induced photodynamic therapy: a novel therapeutic approach to inhibit Candida albicans biofilm.Fungal biofilms, drug resistance, and recurrent infectionBurn wound infections.High-throughput nano-biofilm microarray for antifungal drug discoveryOptimizing a Candida biofilm microtiter plate model for measurement of antifungal susceptibility by tetrazolium salt assayTime course global gene expression analysis of an in vivo Candida biofilm.Quaternized chitosans bind onto preexisting biofilms and eradicate pre-attached microorganisms.Putative role of beta-1,3 glucans in Candida albicans biofilm resistance.Species-specific differences in the susceptibilities of biofilms formed by Candida bloodstream isolates to echinocandin antifungals.Antifungal hydrogels.Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis: review of the literatureParadoxical growth effect of caspofungin observed on biofilms and planktonic cells of five different Candida species.Quaternized chitosan as an antimicrobial agent: antimicrobial activity, mechanism of action and biomedical applications in orthopedicsSustained Nitric Oxide-Releasing Nanoparticles Induce Cell Death in Candida albicans Yeast and Hyphal Cells, Preventing Biofilm Formation In Vitro and in a Rodent Central Venous Catheter ModelReduced biocide susceptibility in Candida albicans biofilmsClinical outcomes of dialysis catheter-related candidemia in hemodialysis patients.Impact of environmental conditions on the form and function of Candida albicans biofilmsBiofilm formation and effect of caspofungin on biofilm structure of Candida species bloodstream isolatesCooperative Evolutionary Strategy between the Bacteriome and Mycobiome.Characteristics of Candida albicans biofilms grown in a synthetic urine medium.Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugs.Fungal Biofilms: Relevance in the Setting of Human Disease.The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation.Candida albicans biofilms produce antifungal-tolerant persister cells.Antifungal, cytotoxic, and immunomodulatory properties of tea tree oil and its derivative components: potential role in management of oral candidosis in cancer patients.Interaction of Candida albicans biofilms with antifungals: transcriptional response and binding of antifungals to beta-glucans.N-trimethylchitosan/alginate layer-by-layer self assembly coatings act as "fungal repellents" to prevent biofilm formation on healthcare materials.Candidiasis in pediatric patients with cancer interned in a university hospital.Candida Species Biofilms' Antifungal Resistance.CD101, a Novel Echinocandin, Possesses Potent Antibiofilm Activity against Early and Mature Candida albicans Biofilms.
P2860
Q28278714-65E9977D-E8E2-4A35-96AF-19C8765805F5Q28539436-C87BE8BD-57AC-4E94-9B8E-D50C22568A61Q30475833-C0890F87-2E5E-41A0-AD73-2B22DA1F3416Q30539101-9D31FF93-23EA-4036-A798-B2773918F353Q33239635-B9747BE7-A438-472C-A695-6DD37FCFA041Q33247523-DC9902F2-B81D-4BE1-8535-08842ADA7538Q33361111-95DF0473-F66E-4342-8F27-A2C846DEF8F8Q33843060-5D78FD4D-9F60-442C-8D09-F9671C29DEE0Q33987312-D0B7A00D-6B39-4D83-A2F3-51FF114F732AQ34045325-C7D3FE9F-0D55-4463-AD4E-46C9E1540CCAQ34339377-9AA318C3-1FBF-4996-892A-123C42985C98Q34355341-AE496884-7BCB-4CB1-8750-2C2AADAD67EDQ34647310-87C18C9E-791D-4E43-8FF5-00F4513B30BCQ34783867-A36D266B-611D-486E-BDA8-71C9B47209D3Q35067093-CC1918DE-32A8-4714-B3B3-7F9AD06319BAQ35175164-BEFDE6B1-C544-4511-8DAA-345A1E732662Q35601615-2405E396-18CD-44A2-89BB-FC5899734373Q35635952-47DFEFBA-4490-4F31-8DC7-23DEE7A2E0E7Q35758901-3580EF51-F6C2-4F9E-9CDD-96213A96D026Q35928823-610EA0BC-9522-4286-97AA-DE084649AD52Q35959484-F8EB8FAC-4B1E-48FA-8367-552A3260C4B5Q36094887-9A816B5D-7072-4751-95C0-8BA48FD3BFFDQ36590145-B2E8128F-4C53-4F04-99A1-DA264D46A26DQ36730043-95D2D583-00B0-4F55-951C-CAF411F72884Q36870880-3012949A-C6B0-483E-8D90-A817B9461357Q37211067-313F92F0-DC0C-4B0F-866A-49AB22D38A90Q37263594-8650D407-1EF0-4171-8F2E-382B18B8C4FEQ37392907-E2C85616-A8D4-473E-A6AD-2DFAAA8ED5ECQ37417375-3AFDF057-2D19-4C87-9630-54A63F163DF9Q37451666-B6C6B1BF-3A8B-4306-AE86-82E243A57771Q37699331-AD2D0C75-3D04-4874-B8B7-95FC632CD7CCQ37887512-85E6CD38-B8B7-4247-A80D-9B1E1E305472Q38949297-17A260D4-16B0-4BFD-B0F3-A2D4FEB87C9AQ39077924-AEA74E4B-6A85-4D6D-B8CE-56F3451F32A0Q39327502-D7674134-5BAB-4912-8C73-A9E4A690B35CQ40335405-EAF37376-F95D-412A-90EA-4F4F3DC4E72BQ40464668-0C37244C-BCB1-45E5-87BE-B59D9C9D3BDEQ42597985-0F2BDF53-95D0-4453-AF33-89A81F0C066CQ48163282-111FD2A9-C86A-4F0E-AAC1-B0CD385C8AB1Q50042600-D31DBEE6-A8F4-4BFE-A3F8-C21C2B8F8476
P2860
Candida biofilms: antifungal resistance and emerging therapeutic options.
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Candida biofilms: antifungal resistance and emerging therapeutic options.
@ast
Candida biofilms: antifungal resistance and emerging therapeutic options.
@en
type
label
Candida biofilms: antifungal resistance and emerging therapeutic options.
@ast
Candida biofilms: antifungal resistance and emerging therapeutic options.
@en
prefLabel
Candida biofilms: antifungal resistance and emerging therapeutic options.
@ast
Candida biofilms: antifungal resistance and emerging therapeutic options.
@en
P1476
Candida biofilms: antifungal resistance and emerging therapeutic options
@en
P2093
Duncan M Kuhn
Mahmoud A Ghannoum
P304
P577
2004-02-01T00:00:00Z